



INFLUENCE OF EXERCISE MODALITY AND MODALITY-SPECIFIC TRAINING ON ENDURANCE 




Jeremy Kenneth Theisen 
Department of Health and Exercise Science 
 
 
In partial fulfillment of the requirements 
For the Degree of Master of Science 
Colorado State University 

















Copyright by Jeremy Theisen 2017 




INFLUENCE OF EXERCISE MODALITY AND MODALITY-SPECIFIC TRAINING ON ENDURANCE 
EXERCISE PERFORMANCE IN HYPOXIA 
 
INTRODUCTION:  In hypoxia, endurance exercise performance is impaired.  The 
magnitude of impairment may be variable between individuals and exercise modalities.  The 
purpose of this study was to determine the influence of exercise modality and modality-specific 
training on hypoxia-mediated performance decrements. 
METHODS: In a randomized cross-over design, endurance trained cyclists (4 males, 3 
females) and rowers (5 males, 3 females) performed exercise on both cycling and rowing 
ergometers.  On separate occasions, participants completed graded exercise tests in normoxia 
(FiO2= 0.21), and standardized exercise (15 minutes, 100 W) and time trials (4 km cycling, 2 km 
rowing) in normoxia and hypoxia (FiO2= 0.15).   
RESULTS:  Hypoxia-mediated performance decrements were not different between 
cyclists and rowers (17±1 vs. 18±1%, p=0.189), cycling and rowing (18±2 vs. 16±2%, p=0473), or 
any combination of training or test modality (p=0.138).  In rowers, peripheral oxygen saturation 
(SpO2) was lower at the end of rowing compared to cycling time trials (78±1 vs. 83±1%, 
p=0.002), and lower than that of cyclists at the end of rowing time trials (78±1 vs. 83±1%, 
p<0.001). 
DISCUSSION:  Hypoxia-mediated performance decrements were not different between 
training modalities, test modalities, or any combination of the factors.  We speculate that 
iii 
reduced SpO2 in rowers at the end of rowing time trials may be related to a greater active 
muscle mass, causing a rightward shift in the oxyhemoglobin dissociation curve and reduced 
transit time of blood in pulmonary capillaries.  In conclusion, SpO2 may be related to active 
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Hypoxia-mediated performance decrements 
With acute exposure to increasing altitude/hypoxia, endurance-exercise performance is 
progressively attenuated.  Hypoxia-mediated performance decrements have been observed 
both in laboratory and controlled field-based experiments (Amann et al., 2006; Gore et al., 
1996; Romer et al., 2007), and by comparing race times of athletes at sea-level to their race-
times at higher altitude 4.   
Prime examples of the effect hypoxia has on performance were the 1968 summer 
Olympic games in Mexico City at 2,240 m (7,350 ft.), during which, surprisingly slow race times 
were recorded for many endurance-type events.  In particular, athletes of rowing events 
seemed to be the especially affected as many cases of dyspnea-related loss of consciousness 
were reported of rowers and some teams could not even finish their event 6.  Failing to 
complete a race for any reason, save for mechanical failures, is atypical of world-class athletes, 
and clearly demonstrates the considerable adverse effects of altitude and hypoxia on 
endurance- exercise performance.  However, the effects of hypoxia are not universal and vary 
between individual athletes and different events, depending on factors including the degree of 
hypoxia 7, type/duration of exercise 3, and the athlete’s aerobic capacity 5,8.   As such, the 
strategy used to maximize performance in one situation, may not be appropriate in another. 
To aid professionals and athletes in preparing for and maximizing performance at 
altitude, this study aims to elucidate how factors such as exercise modality and training 
specificity may influence hypoxia-mediated performance decrements.  In order to understand 
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the interaction between these factors and performance in hypoxia, proper context is gained by 
reviewing the physiological effects of hypoxia on endurance exercise and the differences 
between cycling and rowing. 
Hypoxia and maximal aerobic capacity (VO2max) 
Endurance exercise, or any event beyond two minutes in duration is heavily dependent 
on aerobic metabolism 3.  Therefore, there is a positive relationship between performance and 
one’s VO2max 9, and hypoxia-mediated performance decrements are proportional to the total 
energy provided through aerobic pathways3.   
As altitude increases and the pressure of inspired oxygen (PiO2) falls, VO2max is reduced 
at a rate between five to seven percent for every 1000m gained 3, with significant reductions 
becoming apparent at altitudes as low as 580m 5.  Across various degrees of hypoxia, the 
metabolic cost of a specific exercise at a given workload does not change (Figure 1.1).  
Therefore, a reduction in VO2max either limits maximal power achievable through aerobic 
pathways or increases the relative difficulty of submaximal exercise because the O2 cost of a 





Figure 1.1.  VO2max is reduced from normoxia (N) to hypoxia (H), while the metabolic (O2) cost 
of given workload does not change.  Thus, the O2 cost of exercise in hypoxia represents a 
greater percentage of VO2max, increasing the relative difficulty (adapted from McArdle, et al., 
2010). 
3 
The reduction of VO2max subsequently entrains a proportional reduction of anaerobic 
threshold 8.  In hypoxia, as exercising muscles reach their capacity to produce aerobic power, a 
greater proportion of type II muscle fibers and anaerobic metabolism are required to achieve 
the same power output produced in normoxia 11,12.   However, anaerobic metabolism is not 
sustainable for long durations.  Thus, in hypoxia, either power output must be scaled down or 
high-intensity exercise will lead to premature fatigue and exercise cessation. 
Reduced VO2max in acute hypoxia is a direct result of decreased oxygen delivery (DO2) to 
exercising muscle, or the product of arterial oxygen content (CaO2) and blood flow (BF) (DO2= 
CaO2·BF).  In the investigation of hypoxia-mediated performance decrements, it is necessary to 
examine both variables. 
Decreased PiO2 may account for approximately 41% of the reduction in CaO2 13, but 
there are other important factors that also affect CaO2.  Once air is inhaled into the lungs, the 
next stage in respiration is pulmonary gas exchange in which O2 diffuses across the respiratory 
membrane into the circulation and CO2 is removed.  At rest, the alveolar to arterial O2 tension 
difference ((A-a)DO2) is very low (0-4 Torr), indicating efficient gas exchange 14.  However, (A-
a)DO2 begins to widen (15-20 Torr) at the onset of exercise and is exacerbated by increasing 
intensity 15 and decreased FiO2 13.  Although ventilation perfusion mismatching occurs during 
high-intensity exercise, its effect on (A-a)DO2 is not substantial in acute hypoxia 16 and other 
research indicates that gas exchange during intense exercise in acute hypoxia is primarily 
impaired due to diffusion limitation 17.   
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At rest in normoxia, the diffusion rate of O2 in the lungs is such that O2 tension (PO2) 
quickly reaches equilibrium between alveolar air and blood.  As exercise intensity increases, 
cardiac output (Q� ) increases, reducing red blood cell transit time in the pulmonary circuit 15.   In 
some cases, in highly trained athletes with high Q�  and greater muscle mass recruitment, red 
blood cell transit time is reduced to less than the 0.35 seconds necessary for complete 









Figure 1.2.  Capillary Oxygen tension (PO2) along the distance of a pulmonary capillary at 
rest (blue lines) and during exercise (red lines). In normoxia (top), when the PO2 range is 
higher, blood entering the pulmonary capillary equilibrates with alveolar PO2 (PAO2) quickly.  
However, during high-intensity exercise, increasing cardiac output (Q) limits red blood cell 
transit time in pulmonary capillaries and equilibration may not occur before the end of the 
pulmonary capillary.  At altitude (bottom), the diffusion limitation during exercise is even 
more prominent due to a lower PO2 range (adapted from Boron & Boulpaep, 2011). 
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Still, in normoxia, PO2 remains close to the plateaued upper-section of the oxyhemoglobin 
dissociation curve and EIAH typically only leads to mild to moderate arterial desaturation (88-
92% SaO2) 18.  However, in hypoxia, when resting PO2 is closer to the steep portion of the 
oxyhemoglobin dissociation curve, high-intensity exercise may lead to severe desaturation 
(<88% SaO2) 17 (Figure 1.2), resulting in substantially reduced VO2max and endurance exercise 
performance 5.   
Additionally, CaO2 is influenced not only by PO2, but by [hemoglobin] and factors such as 
pH, PCO2 and temperature.  Athletes recruiting greater relative muscle mass or exercise models 
that require greater muscle mass may experience greater blood pH and temperature 
disturbances, causing a greater right-ward shift in the oxyhemoglobin dissociation curve 20 and 
thus further reduced CaO2.  In accordance, EIAH in hypoxia is greater in more aerobically fit 
individuals 5,7 or exercise models that require greater relative muscle mass 20, such that 
decrements in VO2max may be commensurate with the amount of muscle mass that is recruited.  
It is important to note that more aerobically fit individuals still achieve greater VO2max and 
generally better performance.  However, a disparity in physical fitness or muscle mass 
recruitment, and varying degrees of EIAH between athletes could, in part, explain differences in 
hypoxia-mediated performance decrements. 
The next important factor dictating VO2 is the amount of oxygen that is delivered to 
exercising muscle (DO2, again, the product of CaO2 and BF) 21.  Muscle BF closely matches 
metabolic demand during rest and exercise 22 and has a linear relationship with workload 
without an obvious plateau (Andersen & Saltin, 1985).   However, maximal Q�  is limited: healthy 
males may reach ~30 L·min-1 22–24 and highly trained athletes may  reach ~36 L·min-1 25.  Still, 
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maximal muscle BF may reach values between 300-400 mL·min-1·100 g-1 26–28.  This means that if 
all muscle were maximally perfused, cardiac output would be outstripped by the demand 22,28.  
For example, to maximally perfuse all the muscle of an athlete with 30kg lean muscle mass, the 
necessary Q�  would be ~90-120 L·min-1 (~3 times higher than physiological values).  So, as 
cardiac output nears maximal values, vascular conductance is restrained in order to maintain 
tolerable systemic perfusion pressure and adequate BF to vital organs 29.  Therefore, VO2max and 
performance in any condition are limited by Q�  and the breadth of BF distribution. 
During exercise in acute hypoxia, CaO2 is reduced and maximal Q�  is attenuated 23,30 and 
in combination result in reductions of VO2max in hypoxia.   The reduction of maximal Q�  in 
hypoxia is not thoroughly understood, but may be mediated by factors including autonomic 
changes or myocardial dysfunction 31.  In the face of reduced CaO2 and Q� , BF may be withheld 
from exercising muscle in attempt to maintain adequate DO2 to vital organs, leading to 
attenuated aerobic exercise capacity.  However, certain exercise models may allow adequate 
DO2 in hypoxia if there is sufficient BF or reserve Q� .  For example, research has shown that in 
hypoxia, adequate DO2 is possible during exercise of low intensity 10 or a relatively small muscle 
mass 20 (Figure. 1.2).  Therefore, differences in hypoxia-mediated performance decrements may 
exist between exercise modalities with different BF or Q�  requirements based on differing 







Cycling and rowing 
Cycling and rowing are examples of non-weight bearing and rhythmic aerobic exercise.  
Participation in both modalities ranges from recreational to world class competition.  While 
some similarities exist between the two modalities, the unique characteristics of each modality 
result in different physiological responses and subsequently, distinct training adaptations. 
Between the two modalities, obvious differences are 1) muscle groups engaged, and 2) 
technique.  Cycling exercise primarily engages muscles of the lower body with most of the 
forces produced in the quadriceps muscle group 32. Rowing also relies principally on force 
produced in the lower body but additionally engages muscles of the trunk and upper 
extremities 33.  During competition (cycling 4-km or rowing 2-km races), aerobic metabolism 
contributes 70-80% of the total energy during both cycling and rowing 34–37. 
Cycling is a relatively simple movement pattern that is easily learned and familiar to 
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Figure 1.3.  Maximal cardiac output (Q� ) is reduced from normoxia (N) to hypoxia (H) and 
limits blood flow (BF) to exercising muscle and other tissue.  However, exercise with a 
relatively smaller muscle mass does not require maximal Q�  and in hypoxia, there is adequate 
reserve Q�  to maintain BF to exercising muscle and other tissue (adapted from Calbet, et al., 
2009). 
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arm that turns a flywheel attached by chain.  The alternating and relatively short duty cycles of 
each leg allows nearly continuous force production.  World class male track cyclists (4-km) 
optimize their pedaling rate near 130 rpms 38 and subsequently, relatively small forces applied 
rapidly result in substantial power output 39.    
Conversely, rowing is a more complex movement that may be less familiar to many 
people, compared to cycling 33.  Rowing technique may be quickly learned to an adequate 
degree 33, but high levels of performance are the result of extensive practice and training 40.  
Rowing involves coordination of the upper and lower body in which forces must be transferred 
through the legs, torso and arms to a handle and chain attached to a flywheel.  The rowing 
stroke begins with the extension of both legs and the hip which contributes the majority of the 
power in the stroke followed by a relatively less powerful contribution from the arms and back 
41.   Compared to cycling, the rowing duty cycle is a greater duration that involves a force 
generating “drive” phase, accounting for approximately 53% of the entire cycle, followed by a 
passive “recovery” phase 42.  Elite oarsmen choose a cadence near 35 strokes per minute and 
thus rowing invokes a greater relative force per stroke, but at a slower relative rate compared 
to cycling. 
Between cycling and rowing, some physiological responses are shared, while some are 
distinct.  In subjects previously naïve to the rowing technique (but given instruction and 
practice), peak heart rate and VO2max were not different between the modalities but peak 
power was lower while rowing 43.  During incremental exercise, heart rate, ventilation and VO2 
are higher at each workload during rowing 33.  The differences in physiological response are 
explained in part, by the greater relative muscle mass recruited during rowing 43,44.  Also, 
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calculated efficiency (∆work rate/∆VO2) is lower during rowing: 10-20% 33,45 compared to 
cycling: 22-26% 46.  Therefore, it is possible that proportional hypoxia-mediated performance 
decrements may be greater during rowing compared to cycling due to decreased efficiency.  It 
may also be possible that inefficiency impairs rowing performance to such a degree that the 
added insult of hypoxia may be less apparent during rowing compared to cycling. 
 Different techniques and physiological responses also lead to different training 
programs and physical/physiological profiles between cyclists and rowers.  Cyclists focus on 
lower body training occurring primarily on-bike and may include lower body resistance training 
47, while upper body training is deemphasized. Conversely, rowers train both muscles of the 
upper and lower body in specific (rowing) and non-specific (running, cycling, resistance training) 
modalities 35.  Muscle mass that does not contribute to power production in cycling (i.e. upper 
body) would be extraneous, potentially negatively affecting efficiency 48 and performance 49.  In 
rowers, however, all major muscle groups contribute to the rowing effort and there is a positive 
correlation (r=0.56; p<0.001) 50 between overall body mass and performance.  As such, on 
average, elite male cyclists are typically smaller in overall mass compared to age and sex 
matched elite rowers (approximately 60-75kg vs. 70-90kg, respectively)51,52.  
Any type of endurance-type training leads to central and peripheral adaptations that 
improve aerobic capacity as well as muscular strength and endurance, although adaptations 
may be regionalized with different training modalities.  Central adaptations, such as improved 
stroke volume 53, blood volume and hemoglobin 54, and vascular function 55–57, enhance blood 
flow and DO2 while increased motor output allows more muscle mass to be recruited during 
exercise 58,59.    
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Peripheral adaptations include increased muscle capillary density60, improving O2 diffusion into 
active muscle 61, and improved oxidative capacity of muscle via increased mitochondrial 
density62 and oxidative enzymes 63 within trained limbs only 64 .   Cross sectional area of muscle 
fibers and contractility also increases with training allowing for greater force production 65.   
As a result of training, elite cyclists and rowers possess great aerobic capacity with typical 
VO2max values of approximately 5.5 and 3.85 L·min-1  for male and female cyclists, respectively 
51,66 and 6.3 and 4.5 L·min-1 for male and female rowers, respectively 35.  Maximal aerobic 
power output is also great with typical values of 470 and 333 W for male and female cyclists, 
respectively66 and 422 and 305 W for male and female rowers, respectively  35. 
Due to modality specific training, peripheral adaptations may occur regionally such that 
cyclists experience adaptations primarily in the lower body, while rowers make adaptations in 
the lower and upper body.  Therefore, during rowing exercise in hypoxia, rowers may 
experience a greater hypoxia-mediated performance decrement due to greater active muscle 
mass or conversely, they may experience a less severe hypoxia-mediated performance 
decrement compared to cyclists because the trained muscles of their upper body may be better 
able to extract O2 from the blood.   Another possibility is that the additional muscle mass 
cyclists might engage during rowing is not appreciable enough for hypoxia-mediated 
performance decrements to become apparent.  
Summary 
This review has investigated factors that could potentially influence hypoxia-mediated 
performance differences between cycling and rowing exercise as well as between athletes that 
train in one modality or the other.  Answers to these questions are informed by examining 
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literature that describes the effect of hypoxia on endurance exercise, as well as the differences 
between the two modalities and athletes of one or the other.  Based on the literature, it seems 
that hypoxia-mediated performance decrements between cycling and rowing may be 
influenced by differences in relative active muscle mass requirements and mechanical 
efficiency.  Further, the magnitude of hypoxia-mediated performance decrements may be 
different between cyclists and rowers during rowing due to modality-specific training 
adaptations.   
In the following study, trained cyclists and rowers have performed both cycling and 
rowing exercise tests in normoxia and hypoxia to discern the influence of exercise modality and 




Acute exposure to hypobaric or normobaric hypoxia is accompanied by impaired 
physiological function and reduced exercise capacity/performance.  These impairments may 
have important implications for individuals who must make rapid transitions from low to high 
altitude, such as the military or professional athletes.  As altitude increases or the pressure of 
inspired oxygen (PiO2) falls, maximal aerobic capacity (VO2max) is reduced by five to seven 
percent for every 1000 m elevation gain above sea-level 3.  Thereby, hypoxia-mediated 
performance decrements are most apparent in endurance-type events or any activity that is 
heavily reliant on aerobic metabolism.  However, the magnitude of impairment is not universal 
and may vary between different athletes and exercise modalities.   
Cycling and rowing are both aerobic events of which high-level competition takes place 
in venues world-wide, including many that are above sea-level.  During competition (cycling 4-
km or rowing 2-km races), aerobic metabolism contributes 70-80% of the total energy required 
34–37 and thus performance decrements would be expected in hypoxia 3.  Interestingly though, 
evidence from the 1968 Summer Olympics (Mexico City, elevation: 2,240 m) suggests that 
rowers’/rowing performance may be more severely affected by hypoxia compared to other 
endurance-type athletes or events, including cyclists’/cycling 6.   
Key differences exist between the two exercise modalities and the athletes of each that 
may explain variations in hypoxia-mediated performance decrements.  Cycling and rowing both 
rely principally on the force produced in the muscles of the lower body, although rowing 
engages additional muscle mass of the trunk and upper extremities 32,33.  In subjects previously 
13 
naïve to the rowing technique, heart rate, ventilation and oxygen consumption (VO2) are higher 
during rowing compared to cycling at a given submaximal workload 33, and this may be 
explained in part by the greater relative muscle mass recruited during rowing 67,68.  Also, 
calculated efficiency (∆workrate/∆VO2) is lower during rowing: 10-20% 33,45 compared to 
cycling: 22-26% 46.  Greater O2 demand due to increased active muscle mass and decreased 
efficiency may then lead to greater proportional performance decrements in hypoxia during 
rowing compared to cycling. 
Further, modality-specific adaptations, as well as traits that predispose individuals to 
one modality or the other may lead to different physical profiles between cyclists and rowers 
that may help explain any differences in hypoxia-mediated performance decrements.  For 
example, on average, elite male rowers are heavier than age-matched elite male cyclists 
(approximately 60-75kg vs. 70-90kg, respectively) 51,52.   Concurrently, with more potential 
muscle to recruit during exercise, typical absolute VO2max values also tend to be greater rowers, 
compared to cyclist counterparts (6.3 vs. 5.5 L·min-1) 35,51,66.  As the magnitude of decrements in 
absolute and relative VO2max  in hypoxia has been observed to be positively related to VO2max in 
normoxia5,7, hypoxia-mediated performance decrements may be expected to be greater in 
rowers compared to cyclists. 
The purpose of this study was to determine the influence of exercise modality and 
training specificity on the proportional magnitude of hypoxia-mediated performance 
decrements.  Identifying factors that influence performance in hypoxia, such as exercise 
modality or training specificity, would be of physiological interest to researchers and may 
benefit professionals and those who must perform at high levels during sojourns at high 
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altitude.  We hypothesize that 1) hypoxia-mediated performance decrements will be greater 
during rowing time trials compared to cycling time-trials and 2) hypoxia-mediated performance 
decrements will be greater in rowers compared to cyclists due to a greater amount of active 




From July 2016 through April 2017, 27 healthy adults were recruited for the current 
study.  Inclusion criteria consisted of current participation in either cycling or rowing training 
with at least 11 months of experience; age within the range of 18-55; assessment of blood 
pressure, and 12-lead electrocardiogram during incremental exercise; and physician approval.  
Exclusion criteria included self-reported time-trial times (cycling 4km or rowing 2km) of greater 
than 7:30 (min:sec) for males and 8:30 (min:sec) for females; history of acute mountain 
sickness; and contraindications to performing vigorous exercise.  Each subject gave written 
informed consent after a detailed explanation of the study procedures.  This study was 
approved by the Institutional Review Board at Colorado State University. 
Overview 
After screening, subjects reported to the Human Performance Clinical Research 
Laboratory on 8 separate occasions; subjects performed a graded exercise test on both cycling 
and rowing ergometers, then 3 time trials (practice, normoxic, hypoxic) of both exercise 
modalities.  The study design followed a random cross-over design: Subjects were randomly 
assigned to perform all tests of either modality first, then the other; subjects were also 
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randomly assigned to perform hypoxic or normoxic time trials first, then the other (Figure 2.1).  








During their first visit to the Human Performance Clinical Research Laboratory (HPCRL), 
subjects underwent a screening protocol to determine the safety and suitability of their 
participation:  first, females provided urine samples for pregnancy testing; then blood was 
collected via finger prick and capillary tubes to measure hematocrit and hemoglobin values (Hb 
201+; Hemocue, Ängelholm, Sweden); body composition was assessed via dual-energy x-ray 
absorptiometry (Lunar Radiation Corp, Madison WI; software v. 4.1); and lastly, subjects 
performed a graded exercise test (20-40 W/min continuous ramp until fatigue) on an 
electrically braked cycle ergometer (Velotron; Racermate Inc, Seattle, WA) while 
electrocardiogram tracings (Quinton Q-stress; Mortara Instrument, Millwaukee, WI ) were 
Figure 2.1.  Participant flow diagram.  Not all participants completed the study and not all 
data from completed participants were included in analysis: Data from 4 participants were 
removed; 3 as outliers in age; 1 as an outlier in hypoxia-mediated time trial performance. 
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monitored and recorded, and expiratory gases were analyzed via an automated metabolic cart 
(TrueOne 2400, Parvo medics, Sandy, UT). 
Graded Exercise Tests 
After screening and randomization, subjects reported to the laboratory to perform a 
graded exercise test (GXT) on either a cycle ergometer (Velotron; Racermate Inc., Seattle, WA) 
or rowing ergometer (Model E; Concept2 Inc., Morrisville, VT).  On arrival, participants were 
instrumented for measurement of heart rate (Polar F21, Kempele, Finland) and peripheral 
oxygen saturation (SpO2, finger pulse oximeter, Cardiocap 5, GE Datex-Ohmeda, Madison, WI).  
Heart rate, blood pressure and SpO2 were measured at rest in the supine, sitting and standing 
positions.  Participants were then instructed in proper form if they were not familiar with the 
modality and given time to practice until their form was adequate.  Participants were then 
allowed to warm up at a self-selected, but moderate pace, for up to five minutes.  Before the 
start of the test, subjects were fitted with headgear and a mouthpiece attached to a 3-way, 
non-rebreathing valve (2730 Series; Hans Rudolph, Inc, Shawnee, KS), connected to an 
automated metabolic cart (TrueOne 2400, Parvo medics, Sandy, UT).   The test consisted of 2-
minute work stages followed by a 30-second rest period.  The test began at 100 W for females 
or 150 W for males and increased by 50 W each stage.  The test was terminated either at 
volitional fatigue or once the subject was unable to maintain a cadence above 40 revolutions 
per minute on the cycle ergometer or power output within 10% of the current stage on the row 
ergometer.  Metabolic data was measured continuously as 30-second averages.  Heart rate was 
measured within 15 seconds before the end of each stage and blood pressure, SpO2 and rating 
of perceived exertion (RPE) were measured immediately after each stage. 
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Time Trials 
After the GXT of one modality, subjects returned to the laboratory on separate 
occasions to perform three time trials (4km cycling ergometry or 2km rowing ergometry) of the 
same modality.  First, a practice time trial was performed in normoxia followed by normoxic 
(FiO2=0.21) and hypoxic (FiO2=0.15) time trials in randomized order.  Time trials were 
performed in an environmental chamber within which researchers could manipulate the 
inspired oxygen concentration (Colorado Altitude Training, Louisville, CO).  The elevation of 
Colorado State University (Fort Collins campus) is approximately 1525 m (~5000 ft.) and is 
mildly hypobaric (~640 mmHg).  As such, “normoxia” represents ambient conditions at 1525 m 
and hypoxia represents a simulation of approximately 4300 m (~14000 ft.).    
On arrival, subjects were again instrumented for measurement heart rate (3-lead 
electrocardiogram) (Cardiocap 5, GE Datex-Ohmeda, Madison, WI) and SpO2.  Resting heart 
rate, blood pressure and SpO2 were measured in the supine, sitting and standing positions.  
Subjects then began 15 minutes of standardized exercise at a constant workload of 100 W.  
Based on the training status of the research participants, this workload was supposed to 
represent exercise that could be completed at low- to moderate-intensity in both hypoxia and 
normoxia.  Heart rate was measured within the last 15 seconds of exercise and blood pressure, 
SpO2 and RPE were measured immediately upon completion.  Subjects were then allowed up to 
5 minutes to rest before beginning the time trial.  During the time trial, participants were 
allowed to self-pace, but were encouraged to complete the time trial as quickly as possible.  
Again, heart rate was measured within the last 15 seconds of exercise and blood pressure, SpO2 
and RPE were measured immediately upon completion. 
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Statistical Analysis 
Students T-test was used to compare subject characteristics between cyclists and 
rowers.  Two-way repeated measures analysis of variance (ANOVA) was used to determine the 
influence of exercise modality and training specificity on primary outcome data collected during 
GXTs.  Three-way ANOVA was used to determine the influence of and interaction between 
exercise modality, training specificity and FiO2 condition on primary outcome data collected 
during steady state exercise and time trials. The level of statistical significance was set at 




Nineteen research participants completed all nine study visits and data from fifteen 
were analyzed.  Data from four participants was excluded from analysis due to outliers in age 
(n=3) and performance during the rowing time trials (n=1).  Selected physiological 
characteristics of the research participants are presented in Table 1.   
Table 2.1. Select Participant Characteristics 
 
 
 Data are mean±SE. 
n, Number of participants. 
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One participant was unable to complete the rowing time trial in hypoxia in the first attempt, 
but returned on a separate occasion and was successful.  Aside from this incident, exercise in 
hypoxia was well tolerated.  On average, cyclists were 5 years older than rowers, and rowers 
were slightly heavier than cyclists, but the difference in mass (~ 15 kg) did not attain statistical 
significance (p=0.082).  Other characteristics were similar between the groups.   
Resting data 
Resting heart rate, mean arterial pressure (MAP) and SpO2 measured in the supine 
position during normoxia and hypoxia are presented in Table 2.  In general, compared to 
rowers, cyclists’ resting heart rate and MAP were lower and SpO2 was greater.  In both cyclists 
and rowers, hypoxia increased resting heart rate and reduced SpO2, while there was no 
influence on MAP.  There were no interactions in these resting variables between the groups 
and FiO2 conditions (p<0.05).  
Graded Exercise Tests  
Between cyclists and rowers, VO2max was not different during cycling (3.86±0.25 vs. 
3.79±0.38 L·min-1, p=0.869) or rowing (3.44±0.22 vs. 3.9±0.34 L·min-1, p=0.317) (Figure 2.1A).   
However, VO2max within cyclists was reduced from cycling to rowing (3.86±0.25 vs. 3.44±0.25 
L·min-1, p=0.002), while within rowers, there was no difference between cycling and rowing 
(3.79±0.38 vs. 3.9±0.34 L·min-1, p=0.238) (Figure 2.1A). 
Power output at VO2max was not different between the cyclists and rowers during cycling 
(379±24 vs. 331±27 W, p=0.211) or rowing (264±18 vs. 325±23 W, p=0.114) (Figure 2.1B).
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Table 2.2. Average Hemodynamic Responses in Normoxia and Hypoxia During Rest, Graded Exercise Tests, Standardized Exercise (15 











    Normoxia   Hypoxia   p values   
  Cycling  Rowing  Cycling  Rowing  FiO2  
    Cyclists Rowers   Cyclists Rowers   Cyclists Rowers   Cyclists Rowers      
HRrest  63±4 69±1  63±5 70±4  67±3 76±3  74±3 73±4  0.012 0.036 0.566  
HRGXT  184±3 185±2  178±5 187±4  - -  - -  0.217 0.406 0.206  
HR100W  117±7 124±4  129±7 134±7  133±4 143±6  142±4 152±6  <0.001 0.055 0.014  
HRTT  179±4 185±4  181±3 188±2  177±2 185±3  176±2 184±3  0.195 0.002 0.655  
MAPrest  84±2 89±3  87±1 92±3  83±2 85±2  83±2 88±2  0.183 0.009 0.039  
MAPGXT  121±4  115±3  106±3 115±3  - -  - -  - 0.536 0.068  
MAP100W  96±3 99±2  94±3 98±3  97±3 102±2  96±3 98±2  0.349 0.058 0.409  
MAPTT  110±4 104±3  99±4 107±3  105±4 103±3  98±4 107±3  0.484 0.327 0.285 a,b 
SpO2 rest  99±0 98±1  98±1 98±0  91±0 89±1  91±1 89±1  0.001 0.01 0.597  
SpO2 GXT  90±3 94±1  95±1 92±1  - -  - -  0.14 0.758 0.542  
SpO2 100 W  97±0 97±1  97±0 96±1  80±1 80±2  80±2 77±2  <0.001 0.165 0.383  
SpO2 TT  93±1 91±2  93±1 88±2  71±1 75±1  74±2 68±1  <0.001 0.033 0.109 b,c 
RPEGXT  18±1 18±0  18±1 18±0  - -  - -  - 0.933 0.665  
RPE100W  9±1 9±1  11±1 9±1  11±1 9±1  11±1 10±1  0.046 0.039 0.222  
RPETT   18±1 18±0   18±1 18±1   18±1 18±0   18±1 18±0   0.394 0.736 0.621   
Data are mean±SE 
a
 interaction within cycling between cyclists and rowers 
b
 interaction within rowing between cyclists and rowers 
c
 interaction within rowers between cycling and rowing 
Rest, average resting values; GXT, average values at VO2max during graded exercise tests; 100W, average values at the end of 15 
minutes of standardized exercise at 100 W; TT, average values at the end of time trials; HR, heart rate (beats per minute); MAP, 
mean arterial pressure; SpO2, oxyhemoglobin saturation, RPE, rating of perceived exertion (Borg scale; 6-20). 
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Also, cyclists’ power output at VO2max was reduced from cycling to rowing (379±24 vs. 264±18 
W, p<0.001), while within rowers, there was no difference between cycling and rowing (331±27 
vs. 325±23 W, p=0.666) (Figure 2.2B).  There were no differences in peak heart rate, MAP, SpO2 






VO2 during submaximal GXT stages was lower during cycling compared to rowing (Figure 
2.3, p<0.001) but was not different between cyclists and rowers. Further, efficiency (∆work-
rate/∆VO2), calculated within the first and penultimate stages of cycling and rowing GXTs, was 
not different between cyclists and rowers (30.9±1.2 vs. 31.2 ±1.0, p=0.614), nor cycling and 
rowing (31.6±1.3 vs. 31.0±1.4, p=0.766), and there were no interactions between the groups 
and modalities (p=0.252).   
 
Figure 2.2.  A:  Maximal Oxygen uptake (VO2max) during GXTs.  B:  Power achieved at 
VO2max.  Cyclists’ data are on top; rowers’ data are on bottom.  Bars represent data mean 
values; circles represent individual data points and lines connect data points of the same 








The standardized bout of 100 W for 15 minutes represented low-moderate-intensity 
exercise (~ 22-40% of maximal work rate).  Heart rate, MAP, SpO2, and RPE data from the end 
of the standardized exercise are presented in Table 2.  In general, at the end of standardized 
cycling and rowing exercise, heart rate was lower in cyclists compared to rowers, and lower 
after cycling compared to rowing.  Hypoxia increased the heart rate response, but there was no 
interaction between the groups, modalities and FiO2 conditions (p=0.928).  MAP at the end of 
standardized exercise was not different between the groups, modalities or FiO2 conditions, and 
there were no interactions between them (p=0.583).  Hypoxia decreased SpO2 at the end of 
both cycling and rowing standardized exercise, but there was no difference between the two 
groups or modalities, nor were there any interactions between the groups, modalities or FiO2 
conditions (p=0.399).  Rating of perceived exertion after the standardized exercise was 
increased in hypoxia and was greater in cyclists compared to rowers, but similar between 
cycling and rowing.  RPE was not influenced by any combination of group, modality or FiO2 
condition (p=0.280). 
Figure 2.3.  Oxygen uptake (VO
2
) vs. Power output during cycling and rowing time trials 
between the first and penultimate stages.  Individual data points are represented by circles 
(cyclists) or triangle (rowers).  Lines of best fit are displayed. 
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Time Trials 
Normoxic time trials were not different from habituation trials during cycling or rowing 
time trials (p=0.728).  Cycling and rowing time trial performance was slower in hypoxia for both 
cyclists and rowers (7.13±0.12 vs 7.63±0.12 minutes, p=0.005), although in both groups, cycling 
times were faster than rowing times (6.76±0.12 vs. 7.99±0.12minutes, p<0.001) (Figure 2.4A, 
2.4B).  In general, cycling time trials were similar between cyclists and rowers (6.65±0.18 vs 
6.87±0.17 minutes, p=0.359), and cyclists completed rowing time trials slower than rowers 
(8.27±0.18 vs. 7.70±0.17 minutes, p=0.39) (Figure 2.4A, 2.4B).  However, there were no 
interactions between the groups, modalities and FiO2 conditions (p=0.798).  Examination of the 
proportional magnitude of hypoxia-mediated performance decrements ((∆hypoxia time trial-
normoxia time trial) · normoxia time trial-1) revealed no difference between cyclists and rowers 
(7±0 vs 8±0%, p=0.059), nor between cycling and rowing (8±1 vs. 6±1%, p=0.135), and no 
interactions (p=0.138) (Figure 2.4C).  
Average power output data during the time trials were also considered as an index of 
aerobic performance and thus were also analyzed.  In alignment with time to completion data, 
hypoxia, as a main effect, reduced the average power output during both cycling and rowing 
(256±10 vs. 210±10 W, p=0.003), average power output was greater while cycling (253±10 vs. 
212±10 W, p=0.007); and there was no overall difference between cyclists and rowers (227±11 
vs. 238±10 W, p=0.441) (Figure 2.5A, 2.5B).  However, cyclists and rowers maintained similar 
power output during cycling (262±15 vs. 244±14 W, p=0.579) (Figure 2.5A), while, cyclists’ 
average power output was slightly lower than rowers’ during rowing (191±15 vs. 233±14, 












Figure 2.4.  A:  Time to complete the cycling time trials (4-km).  B:  Time to complete the 
rowing time trials (2-km). C: Magnitude of the hypoxia-mediated performance decrement 
during cycling and rowing time trials.  Cyclists’ data are on top; rowers’ data are on bottom.  
Bars represent data mean values; circles represent individual data points and lines connect 
data points of the same individual in normoxia and hypoxia. 
Figure 2.5.  A:  Average power output (W) during the cycling time trials (4-km).  B:  
Average power during the rowing time trials (2-km).  C: Magnitude of hypoxia-
mediated performance decrement during cycling and rowing time trials. Cyclists’ data 
are on top; rowers’ data are on bottom.  Bars represent data mean values; circles 
represent individual data points and lines connect data points of the same individual 
in normoxia and hypoxia. 
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Also, between the two modalities, cyclists’ power output was much greater during cycling 
compared to rowing (191±15 vs. 233±14 W, p=0.002) (Figure 2.5A, 2.5B), while rowers’ power 
output was similar between cycling and rowing (244±15 vs. 233±14 W, p=0.579). There was no 
interaction between groups, modalities and FiO2 conditions (p=0.540).  The proportional 
magnitude of hypoxia-mediated reduction in average power output during the time trials was 
not different between cyclists and rowers (17±1 vs 18±1%, p=0.189), nor between cycling and 
rowing (18±2 vs. 16±2%, p=0.473) (Figure 2.5C) and there was no interaction between groups, 
modalities and FiO2 conditions (p=0.138). 
Values of heart rate, MAP, SpO2 and RPE at the end of the time trials are presented in 
Table 2.  Heart rate at the end of the time trials was lower in cyclists compared to rowers, but 
similar between the two modalities and FiO2 conditions, and there was no interaction between 
the groups, modalities and FiO2 conditions (p=0.979).  MAP at the end of the time trials was not 
different between groups, modalities, nor FiO2 conditions.  However, MAP in cyclists was 
greater after cycling but lower than rowers after rowing.  No interaction existed between the 
groups, modalities and FiO2 conditions (p=0.979).  As a main effect, SpO2 in both cyclists and 
rowers at the end of the time trials was reduced in hypoxia (Figure 2.6).  Cyclists desaturated 
less than rowers, but there was no difference between the modalities (Figure 2.6).  Specific to 
rowers, SpO2 was lower after rowing compared to cycling, and during rowing, cyclists’ SpO2 was 
greater than that of rowers (Figure 2.6).  No interaction existed though when groups and 
modalities were also compared with FiO2 conditions (p=0.096).  RPE after the time trials was 










The purpose of the current study was to determine whether hypoxia-mediated 
performance decrements are influenced by exercise modality and training specificity.  The 
major findings of our study were: 1) Hypoxia-mediated performance decrements during cycling 
(4-km) and rowing (2-km) time trials were not significantly different between the cyclists and 
rowers, or between any combination of group and modality. 2) SpO2 at the end of cycling and 
rowing time trials in normoxia and hypoxia was lower in rowers compared to cyclists, and lower 
at the end of cycling compared to rowing.  3) Specifically, SpO2 after rowing was lower in rowers 
compared to cyclists, and rowers’ SpO2 was lower after rowing compared to cycling.  Although 
these differences in SpO2 did not account for differences in the functional outcomes of time 
trial performance (time to completion or average power output), these data may help explain 
Figure 2.6.  A:  Average magnitude of exercise induced arterial oxygen desaturation (%)(SpO2rest-
SpO2endTT) during cycling time trials (4-km). B:  Average magnitude of exercise induced arterial 
oxygen desaturation during the rowing time trials (2-km).  Cyclists’ data are on top; rowers’ data 
are on bottom.  Bars represent data mean values; circles represent individual data points and 
lines connect data points of the same individual in normoxia and hypoxia. 
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how hypoxia-mediated performance decrements could be greater in rowers/rowing compared 
to cyclists/cycling in other situations (i.e. longer-duration time trials, or elite-level athletes). 
Hypoxia-mediated performance decrements are determined by the body’s ability to: 1) 
transfer O2 from the lungs into circulation, 2) deliver O2 to exercising muscle, and 3) utilize O2.  
The differences between cycling and rowing, and between the physical characteristics of 
cyclists and rowers could influence these capabilities, so as to elicit greater performance 
decrements in hypoxia during rowing compared to cycling, or in rowers compared to cyclists. 
During exercise in hypoxia, the magnitude of pulmonary O2 diffusion impairment can be 
influenced by the amount of muscle mass recruited during exercise.  Greater muscle mass 
recruitment requires greater Q�  causing a greater disturbance in blood pH and temperature 
leading to a rightward shift in the oxyhemoglobin dissociation curve leading to less SaO2 for a 
given PO2.  Greater Q�  also reduces red blood cell transit time through pulmonary capillaries, 
potentially disallowing complete oxygen tension (PO2) equilibration 18.  In combination, these 
mechanisms may explain the modulating effect of muscle mass on SaO2. 
It is likely that differences existed in the amount of active muscle mass used by cyclists 
and rowers during cycling and rowing that influenced pulmonary O2 diffusion, contributing to 
the observed differences in SpO2.  Unfortunately, electromyogram data were not included in 
this study, but possible differences in active muscle mass may be alluded to by anthropometric, 
GXT and time trial data.  In this study, there were no statistical differences between cyclists and 
rowers in body mass, but rowers tended to be heavier (p=0.082) and in other studies profiling 
elite cyclists and rowers, elite rowers are generally greater in mass 51,52.  By itself, mass may not 
be a useful parameter, but combined with greater VO2max values in elite rowers compared to 
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elite cyclists 35,51,66, it may be evidence of greater potential muscle mass capable of performing 
work.  In the current study, VO2max was not different between cyclists and rowers within either 
modality, but it is important to acknowledge that these participants were well-trained, but not 
elite athletes.  However, VO2max and power output at VO2max of cyclists was reduced from 
cycling to rowing, indicating an attenuation of active muscle mass from cycling to rowing.  This 
is further supported by longer time to completion and lower average power output of cyclists 
during rowing time trials.  Cycling exercise primarily engages muscles of the lower body with 
most of the forces produced in the quadriceps muscle group 32, and extensive training in this 
modality may lead to a relative structural underdevelopment of cyclists’ arms compared to 
their well-developed legs; that is, the ligaments and tendons of the arms may not be able to 
tolerate the maximal force potential of the legs.  It is then possible, that within cyclists, the 
additional muscle mass of the upper body recruited during rowing does not outweigh the 
unexploited muscle mass of the legs.  In contrast, rowers, who train both upper and lower body 
35, may have better coordination of simultaneous leg-extension 69, and better developed arm 
structure, thus allowing rowers to recruit a greater proportion of muscle mass during rowing.  
This may be supported by the rowers’ faster time to completion during rowing time trials with a 
slightly greater average power output compared to cyclists (191±15 vs. 233±14, p=0.053) 
(Figure 2.5B).  While it is clear that SpO2 was lowest in rowers while rowing, definitive 
conclusions as to the cause of reduced SpO2 cannot be drawn from these data.  However, these 
data align with previous research implicating active muscle mass as a factor influencing SaO2 
5,7,20 and could indicate a potential for greater hypoxia-mediated decrements in rowers’/rowing 
compared to cyclists’/cycling performance.  Another explanation for decreased SpO2 during 
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rowing could be relative hypoventilation due to the cramped position of rowing and impaired 
diaphragmatic excursion. However, ventilatory data were not collected during time trials, and 
GXT data as well as prior research suggests that ventilation is not impaired during rowing 70.  
Future investigations including measurements of muscle activation, Q� , blood pH and 
temperature would help elucidate the influence of active muscle mass on pulmonary O2 
diffusion between these two types of athlete and exercise modality. 
Beyond contributing to a pulmonary O2 diffusion limitation, greater active muscle mass 
in rowers while rowing could negatively impact aerobic performance in hypoxia through 
limitations in BF distribution and DO2.  Greater muscle activation would require a greater Q�  to 
perfuse all the active muscle mass and is limited by maximal Q�  22,26,28.  Research has also shown 
that maximal Q�  is reduced in acute hypoxia30, perhaps as a mechanism to protect from 
myocardial hypoxia 23.  This may further reduce BF and DO2, but if the exercise model does not 
elicit maximal Q�  in normoxia, such as during exercise with a small relative muscle mass, Q� , BF 
and DO2 may be preserved in hypoxia 20.  If less muscle mass were recruited in cyclists/cycling 
compared to rowers/rowing, there may be a smaller perturbation to systemic BF and DO2, 
thereby limiting the magnitude of hypoxia-mediated performance decrements in 
cyclists/cycling.  Although there were no significant differences in the proportional hypoxia-
mediated decrements in performance between the groups or modalities, performance (time to 
completion) was slightly more affected by hypoxia in rowers compared to cyclists (p=0.059), 
supporting the notion above.  These data are interpreted cautiously though, due to the 
methodology used; participants were not blinded to their power output during the time trials, 
which would allow participants to pace themselves, adding a psychological aspect to their 
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performance, thereby negating a truly physiological response to hypoxia.  However, these data 
may have validity still as athletes would have performance feedback during real-competition. 
The third factor that could influence exercise performance in hypoxia is O2 utilization.  
During cycling and rowing GXTs in this study, VO2 at a given workload was consistently higher 
during rowing compared to cycling and efficiency between the first and penultimate stages was 
similar between the groups and modalities.  Prior research has also shown the O2 cost of 
submaximal exercise at a given workload to be greater during rowing compared to cycling 
33,71,72.  Present efficiency data, though, contrasts with prior findings of lower efficiency values 
during rowing compared to cycling (10-20% vs. 22-26%) 33,45,46.  This difference is possibly due 
to our efficiency calculations beginning at either 100 or 150 W for females and males 
respectively, as we did not collect VO2 from the start of exercise.  If rowing is in fact less 
efficient than cycling, it may be due, in part, to a longer and more complex kinetic chain 
between the points of force application (the feet and the flywheel), thus requiring the 
recruitment of a greater amount of muscle mass for a given workload 72.  Further, the disparate 
patterns of force generation between cycling and rowing could influence the efficiency of either 
modality, although it is not clear how the quick and nearly continuous force production during 
cycling compares to the relatively longer duration of stroke and recovery during rowing.  In any 
case, greater O2 cost and decreased efficiency during rowing could conceivably lead to greater 
impairment of performance in O2-scarce environments.  Another consideration is that 
endurance training of any muscle improves O2 utilization of that muscle through increased 
muscle capillary density 60, improving O2 diffusion into active muscle 61, and improved oxidative 
capacity of muscle via increased mitochondrial density 62 and oxidative enzymes 63 within 
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trained limbs only 64.  In theory, peripheral adaptations in the upper bodies of rowers could 
endow them with greater tolerance to hypoxia during rowing compared to cyclists, who’s 
capacity to utilize O2 in the muscles of their upper body may not be as great.  However, 
measurement of oxidative capacity of muscles was beyond the scope of this study and there 
were no differences in hypoxia-mediated performance decrements beside. 
Although the results of the current study may provide insights to the modulation of 
performance in hypoxia, several limitations in the current study restrict full confidence in our 
results.  Notably, the populations of each group were quite small and may not have 
represented explicitly distinct phenotypes of elite cyclists or rowers.  Although, all participants 
were well-trained and physically fit, anthropometric and performance data is not comparable 
to elite-level athletes.  Also, due to geographical location, in Fort Collins, CO., where high level 
rowing competition is not prolific, recruitment of well-trained rowers was limited to the CSU 
club rowing team, leading to a disparity in age, and possibly skill, between the two groups.  
Differences between the two groups would likely be clearer if they were of the highest caliber 
athlete in each modality and more closely age matched, with a greater number of participants.   
Further, the inherent differences between cycling and rowing technique may obscure the 
physiological responses to exercise in hypoxia.  Although adequate cycling and rowing 
technique are easily learned 33, increased rowing experience would likely lead to greater 
proficiency and possibly different results than those of the current study.  Additionally, the 
pattern of leg muscle activation is different between the two modalities.  A cleaner model to 
investigate the modulating effect of muscle mass in hypoxia might use arm and leg cycle 
ergometry, in which arm cycling is added to leg cycling and there is no change in the technique 
32 
used to activate leg muscle mass.  While this might be a more physiologically sound 
experiment, the comparison of cycling and rowing, two modalities of world-wide competition, 
has valid application.  Also, allowing participants to view performance feedback during time 
trial performance severely limits the interpretation of the physiological response to exercise in 
hypoxia.  However, as mentioned before, performance during real competition would involve 
the integration of feedback, thus representing an environment similar to competition.  Further, 
since hypoxia had main effects on SpO2 and time trial performance, we are confident in the 
validity of our hypoxic stimulus even though it was not a purely physiological response.  
Further, despite the mildly hypoxic ambient conditions of Fort Collins (elev. 1,525 m; 5,003 ft), 
the validity of our hypoxic stimulus is again supported by performance decrements in this 
study, as well as others conducted in similar conditions 73.  Lastly, pertaining to SpO2 data, 
peripheral pulse oximetry has been shown to be valid and reliable, although with a ±1.5% 
standard error of estimation, it is not as accurate as direct arterio-venous blood sampling 18.  
Some SpO2 measurements from the end of exercise in this study were lower than SaO2 in 
athletes at the end of maximal exercise in some other studies: 70% 7; 77% 74; and 86% 5, 
bringing the validity of our SpO2 results into question.  However, these studies all used cycling 
exercise, whereas the lowest SpO2 values measured in this study were in rowers while rowing.  
In line with our hypothesis, it is possible that the increased muscle mass recruited by rowers 
during rowing influenced pulmonary O2 diffusion, such that arterial blood is in fact less 
saturated at the end of intense exercise.  However, it is also possible that SpO2 measurements 
in rowers were influenced by having more callused hands than other athletes due to 
specificities within their training, although this notion is hypothetical. 
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In summary, rapid transition from normoxic to hypoxic environments is accompanied by 
substantial decrements in SpO2 and exercise performance.  In this study, hypoxia-mediated 
performance decrements during cycling and rowing were not different between cyclists and 
rowers, or any combination therein.  However, SpO2 at the end of the time trials was lower in 
rowers and specifically, lower after rowing compared to cycling and lower than in cyclists during 
rowing.  It is possible that differences in SpO2 during exercise are modulated by the amount of 
muscle mass utilized for a specific exercise modality and could lead to differences in hypoxia-
mediated performance decrements.  Although these notions were not substantiated in this 
study, differences in hypoxia-mediated performance decrements may be more pronounced in a 
greater hypoxic stimulus, longer-duration events, or highly specialized/elite athletes.  
Therefore, the strategy used to maximize performance in one instance may not be appropriate 
in another.  These data may help inform those interested in exercise performance in hypoxic 
environments, but further investigation is necessary to discern the full modulating potential of 
muscle mass on SpO2 and exercise performance in hypoxia.  
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  Consent to Participate in a Research Study  
Colorado State University  
  
TITLE OF STUDY:  Endurance Exercise in Low Oxygen: Influence of Muscle   
      Mass and Modality-Specific Training Status  
  
PRINCIPAL INVESTIGATOR:   
Christopher Bell, Ph.D.  
Department of Health and Exercise Science  
Colorado State University  
Fort Collins  
CO 80523-1582  
  
Telephone: 970-491-3495  
Fax: 970-491-0445  
Email: physiology@cahs.colostate.edu  
  
WHY AM I BEING INVITED TO TAKE PART IN THIS RESEARCH?   
You are a healthy endurance trained adult man or woman aged between 18 and 50 years. You 
are a competitive cyclist or a competitive rower.  You have been competing for at least one 
year.  
  
WHO IS DOING THE STUDY?  
Christopher Bell, Ph.D., an associate professor in the Department of Health and Exercise 
Science at Colorado State University will perform this research. Trained graduate and 
undergraduate students will assist Dr. Bell.     
  
WHAT IS THE PURPOSE OF THIS STUDY?  
In a low oxygen environment, such as high altitude, endurance exercise performance is 
impaired.  The degree of impairment may be related to the amount of active muscle.  That is, 
the more muscle needed to perform an exercise, the worse the effect of low oxygen on 
exercise performance. Cycling relies mostly on the muscles of the legs, but rowing involves 
legs, arms, and trunk muscles.  We wish to find out if rowing performance will be impaired to a 
greater extent than cycling performance.  In addition, as a result of endurance training, the 
ability to deliver blood and oxygen to active muscles during exercise is improved.  We also wish 
to determine if frequent training on a specific exercise machine will influence the effect of low 
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oxygen.  To do this we will study cyclists and rowers in normal oxygen, and in a low oxygen 
environment, while cycling and rowing.   
     
WHERE IS THE STUDY GOING TO TAKE PLACE AND HOW LONG WILL IT LAST?   
All of the procedures (unless otherwise stated) will take place in the Human  
Performance Clinical/Research laboratory (HPCRL) in the Department of Health & Exercise 
Science (Moby Complex).   This whole research project will take place over a period of 
approximately 1 year.  You will be asked to be involved for approximately 6-8 weeks.  The total 
time of your participation will be approximately 10 hours spread over 9 visits.   
  
WHAT WILL I BE ASKED TO DO?   
  
Screening Visit ~ 2 Hours  
The first visit to the HPCRL will be a screening visit.  During this visit we will make sure that 
participation in this study is right for you.  
  
Medical Questionnaire  
You will be asked to answer several pages of questions related to your health, any illness you 
may have or have had, and medications you use or have used in the past.   
  
Pregnancy Test   
If you are female you will be required to have a sample of your urine tested for the presence of 
human chronic gonadotropin (HCG), a hormone that indicates whether you may be pregnant.  
This will require approximately 1 cup of your urine. If you are pregnant or the test indicates 
that you are pregnant you will not be able to participate in this study. (Duration: 5 minutes)   
                
Body Composition  
We will measure how much fat you have in your body using a test called dual energy x-ray 
absorptiometry (DEXA).  The DEXA test requires you to lie quietly on a padded table while a 
small probe gives off low-level x-rays and sends them over your entire body.  This test gives 
very accurate measurements of your body fat and bone mineral density.  We will also measure 
the circumference of your waist and hip using a tape measure. (Duration: ~ 15 minutes)  
  
Exercise Stress Test  
You will be asked to perform a vigorous exercise test.  This test will tell us if your heart is 
healthy.  You will be asked to walk on a motorized treadmill or ride an exercise cycle (cycle 
ergometer) for approximately 10-15 minutes. The exercise will become more difficult every 2 
minutes.  While you are walking/riding we will measure your heart rate with an 
electrocardiogram (ECG) and your blood pressure with a cuff placed around your upper arm.  
We will also ask you to wear a nose clip (something that stops you breathing through your 
nose) and ask you to breathe through a mouthpiece.  This will let us measure the gases you 
breathe. Depending on your age and health history, a physician may supervise the test.  If we 
do not think your heart is healthy you will be referred to your primary care physician for 
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further testing.  There is a chance that you may not be allowed to take part in our study. 
(Duration: ~ 60 minutes)  
  
You will be asked to complete 4 cycling visits and 4 rowing visits.  A coin toss will be used to 
decide if you will complete the cycling visits first, or the rowing visits first (e.g. heads=cycling, 
tails=rowing).  
  
Cycling Visit 1 – less than 1 hour  
You will be asked to perform a vigorous exercise test, also know as a VO2max test. You will be 
asked to ride an exercise cycle (cycle ergometer) for approximately 10-15 minutes. The 
exercise will be easy in the beginning but will become progressively harder until you are no 
longer able to exercise.  While you are riding we will measure your heart rate.  We will also ask 
you to wear a nose clip (something that stops you breathing through your nose) and ask you to 
breathe through a mouthpiece.  This will let us measure the gases you breathe and let us 
calculate your VO2max.   
  
Cycling Visit 2 – less than 1 hour  
You will be asked to complete a practice test that will be the same as the tests you complete in 
visits 3 and 4.  You will ride an exercise cycle for 15 minutes.  The exercise will be easy.  You will 
then be asked to ride the exercise cycle a distance equivalent to 4 km (a little less than 2.5 
miles).  The purpose of the test is for you to cycle this distance as fast as possible, as if it were a 
race.  
  
During this test we will measure your heart rate, blood pressure, and the amount of oxygen in 
your blood.  We also ask you how much effort you are putting in to the exercise.  
  
Cycling Visits 3 and 4 – less than 1 hour each  
These visits will take place in an environmental chamber, a special room in which the air you 
breathe can be changed.  During one visit you will breathe normal air.  Normal air contains 21% 
oxygen.  During the other visit the amount of oxygen in the air will be decreased to 
approximately 15%.  This might feel like being on top of a mountain that is 14,000 ft above sea 
level.   
  
A coin toss will be used to decide if you will complete the normal air visit first, or the low 
oxygen visit first (e.g. heads=normal air, tails=low oxygen).  
  
Each visit will begin with 15 minutes of sitting.  The remainder of the visit will be exactly like 
cycling visit 2.  
     
Rowing Visit 1 – less than 1 hour  
You will be asked to perform a vigorous exercise test, also know as a VO2max test. You will be 
asked to exercise on a rowing machine for approximately 10-15 minutes. The exercise will be 
easy in the beginning but will become progressively harder until you are no longer able to 
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exercise.  While you are rowing we will measure your heart rate.  We will also ask you to wear 
a nose clip (something that stops you breathing through your nose) and ask you to breathe 
through a mouthpiece.  This will let us measure the gases you breathe and let us calculate your 
VO2max.   
  
Rowing Visit 2 – less than 1 hour  
You will be asked to complete a practice test that will be the same as the tests you complete in 
visits 3 and 4.  You will exercise on a rowing machine for 15 minutes.  The exercise will be easy.  
You will then be asked to row a distance equivalent to 2 km (a little less than 1.25 miles).  The 
purpose of the test is for you to row this distance as fast as possible, as if it were a race.  
  
During this test we will measure your heart rate, blood pressure, and the amount of oxygen in 
your blood.  We also ask you how much effort you are putting in to the exercise.  
  
Rowing Visits 3 and 4 – less than 1 hour each  
These visits will take place in an environmental chamber, a special room in which the air you 
breathe can be changed.  During one visit you will breathe normal air.  Normal air contains 21% 
oxygen.  During the other visit the amount of oxygen in the air will be decreased to 
approximately 15%.  This might feel like being on top of a mountain that is 14,000 ft above sea 
level.   
  
A coin toss will be used to decide if you will complete the normal air visit first, or the low 
oxygen visit first (e.g. heads=normal air, tails=low oxygen).  
  
Each visit will begin with 15 minutes of sitting.  The remainder of the visit will be exactly like 
rowing visit 2.  
  
Prizes  
When you have finished the study we will add your exercise times from the cycle visits 3 and 4 
to your exercise times from rowing visits 3 and 4.  When the study is over for everyone, we will 
compare all of the exercise times.  The man and woman with the fastest total times will each 
be given $50.  The man and woman with the second fastest total times will each be given $30.  
The man and woman with the third fastest total times will each be given $20.  The man or 
woman whose total time is in the middle (i.e. equal number of participants who finished faster 
and slower) will be given $10.  
  
All of the times will be made available to all of the subjects, but the names of the study 
participants, including yours, will be in code. You will not know the identity of the other study 
participants, and they will not know your identity.      
   
ARE THERE REASONS WHY I SHOULD NOT TAKE PART IN THIS STUDY?  
You will not be allowed to participate in these studies for any of the following reasons:   
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1) You are pregnant.  
2) You are younger than 18 or older than 50 years.  
3) You suffer from a disease of the cardiovascular system.  
4) You have asthma or any other type of lung/respiratory dysfunction.  
5) Your resting oxygen saturation < 95% (we will measure this for you).  
6) A contraindication was identified during the screening visit (e.g. positive stress test).  
7) You have experienced and/or have been treated for seizures.  
8) You use performance enhancing drugs.  
  
WHAT ARE THE POSSIBLE RISKS AND DISCOMFORTS?   
It is not possible to identify all potential risks in research procedures, but the researcher(s) 
have taken reasonable safeguards to minimize any known and potential, but unknown, risks. 
The Human Performance Clinical Research Laboratory has emergency supplies including a 
medicine trolley equipped with heart machines and supplemental oxygen.  The investigator has 
a great deal of experience with all of the procedures.  Some of the procedures for which you 
are being asked to volunteer have a number of associated risks:  
  
Body Composition  
The risks associated with the DEXA are very low.  The maximum radiation dose you will receive 
in this study is less than 1/3000th of the federal and state occupational whole body dose limit 
allowed to radiation workers.  Put another way, you will receive less than 1.3 mrem from this 
scan and you already receive approximately 450 mrem /year from normal background 
radiation dose in Colorado.  The more radiation you receive over the course of your life, the 
more the risk increases of developing a fatal cancer or inducing changes in genes.  The 
radiation dose you receive from this scan is not expected to significantly increase these risks, 
but the exact increase in such risks is not known.  There are no discomforts associated with this 
procedure. Women who are or could be pregnant should receive no unnecessary radiation and 
should not participate in this study.  
  
Breathing Air Containing Less Oxygen Than Normal Room Air  
The risks associated with breathing a gas that contains less oxygen than normal room air 
include nervousness and shakiness, perspiration, dizziness or lightheadedness, nausea (feeling 
sick), sleepiness, confusion, difficulty speaking, and feeling anxious or weak.  We will measure 
your heart rate, oxygen saturation (how oxygen you have in your blood), and blood pressure; if 
resting oxygen saturation falls below 70%, resting heart rate increases by more than 50 beats 
per minute, or resting blood pressure increases by more than 35 mmHg, the test will be 
terminated. Should you decide you no longer wish to continue breathing the low oxygen air, 
you will be able to leave the low-oxygen room and immediately begin breathing normal air.   
Supplemental air (100% oxygen) will be available on request or if needed.  Symptoms 
associated with low oxygen can be treated very, very quickly by breathing normal room air 




During any exercise there is a risk that your heart will stop working.  Exercise may make you 
feel tired and/or sick.  Rowing exercise may hurt your hands (e.g. blisters).  During cycle 
exercise the bike seat can be uncomfortable.   
  
ARE THERE ANY BENEFITS FROM TAKING PART IN THIS STUDY?   
There are no direct benefits in participating, however you will receive a copy of your results 
and information pertinent to your fitness and body composition (i.e. height and weight. You 
will be provided with a copy of your DEXA scan; you may wish to have this interpreted by a 
medically qualified professional.   
  
DO I HAVE TO TAKE PART IN THE STUDY?  
Your participation in this research is voluntary. If you decide to participate in the study, you 
may withdraw your consent and stop participating at any time without penalty or loss of 
benefits to which you are otherwise entitled.    
   
WHAT WILL IT COST ME TO PARTICIPATE?   
Other than transport to and from the lab, your participation should incur no costs.  
  
WHO WILL SEE THE INFORMATION THAT I GIVE?   
We will keep private all research records that identify you, to the extent allowed by law.  
  
Your information will be combined with information from other people taking part in the 
study. When we write about the study to share with other researchers, we will write about the 
combined information we have gathered. You will not be identified in these written materials. 
We may publish the results of this study; however, we will keep your name and other 
identifying information private.  We may be asked to share the research files with the CSU 
Institutional Review Board ethics committee for auditing purposes. If you receive a prize, your 
identity/record of receiving a prize (NOT your data) may be made available to CSU officials for 
financial audits.  
    
CAN MY TAKING PART IN THE STUDY END EARLY?   
Your participation in the study could end if you become pregnant, or if you miss any of the 
scheduled appointments.    
  
WILL I RECEIVE ANY COMPENSATION FOR TAKING PART IN THIS STUDY?   
You will not receive any compensation for taking part in this study.  
  
Should your participation in the study end early, you will still receive feedback pertaining to 
your health and fitness.    
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WHAT HAPPENS IF I AM INJURED BECAUSE OF THE RESEARCH? We will arrange to get you 
medical care if you have an injury that is caused by this research.  However, you or your 
insurance company will have to pay for that care. The Colorado Governmental Immunity Act 
determines and may limit Colorado  
State University’s legal responsibility if an injury happens because of this study. Claims against 
the University must be filed with Colorado State University within 180 days of the injury.    
WHAT IF I HAVE QUESTIONS?        
Before you decide whether to accept this invitation to take part in the study, please ask any 
questions that might come to mind now.  Later, if you have questions about the study, you can 
contact the investigator, Christopher Bell at physiology@cahs.colostate.edu or 970-491-3495. 
If you have any questions about your rights as a volunteer in this research, contact the CSU IRB 
at: RICRO_IRB@mail.colostate.edu; 970-491-1553.  We will give you a copy of this consent 
form to take with you.  
     
WHAT ELSE DO I NEED TO KNOW?   
Your signature acknowledges that you have read the information stated and willingly sign this 
consent form.  Your signature also acknowledges that you have received, on the date signed, a 
copy of this document containing 8 pages.  
  
  
_________________________________________  _____________________  




_________________________________________  _____________________  




_______________________________________   _____________________  




_________________________________________     
Signature of Research Staff     
 
 
